These red cell diseases can be the result of multiple genetic causes; the main one being the acquired V617F mutation in the JAK2 gene [present in more than 95% of Polycythemia Vera (PV) cases] causing constitutive activation of the JAK2 kinase in cell lines. Here, JAK2 is linked to acquired polycythemia vera.